Leveraging a disulfidptosis-based signature to improve the survival and drug sensitivity of bladder cancer patients

Abstract

Our study highlighted the disulfidptosis in the regulation of tumor progression, sensitivity to therapy, and survival of BCa patients. POU5F1 and CTSE may be potential therapeutic targets for the clinical treatment of BCa.